Löfgren Syndrome: Do You Know the Signs &amp; Symptoms?

For the answer, click here.

Question 2:

NEXT QUESTION »

For the answer, click here.

Question 3:

A 55-year-old man with a past medical history significant for type 2 diabetes mellitus presents with a 1-week history of a hot, swollen right foot.

NEXT QUESTION »

For the answer, click here.

Question 4:

NEXT QUESTION »

For the answer, click here.

Question 5:

ANSWER KEY »

Atlantic Health System Tests Novel CAR-T Cell Therapy for Lupus in First US Patient

ANSWER KEY:

Question 1. E

Question 2. E

Question 3. C

Question 4. B

Question 5. E

Related Content

February 19th 2024

Antiplatelet Therapy With Aspirin: What Dose in Primary and Secondary Prevention?

In the open-label, phase 1 study, participants' own T cells will be extracted and engineered to target and eliminate autoreactive B cells and to potentially reset the immune system.

June 15th 2012

New-Onset Inflammatory Rheumatic Diseases May be Triggered by SARS-CoV-2 Infection or COVID-19 Vaccines, According to Recent Data

Use of aspirin in primary prevention of cardiovascular disease must be based on individual risk-benefit analysis and is not appropriate for patients at low risk.

August 25th 2023

The New Oral Anticoagulants: Benefits, Risks, Patient Selection

Findings from a recent study show a broad spectrum of possible clinical manifestations of IRD following SARS-CoV-2 infection or COVID-19 vaccination.

May 22nd 2012

First Opioid Rx Leads to Long-term Use in 1 of 5 with Rheumatic or Musculoskeletal Disorders

The European Society of Cardiology just weighed in on the 3 new alternatives to warfarin for oral anticoagulation. The response is tempered enthusiasm.

May 17th 2023

Allopurinol May Help Prevent First ACS Event in Patients with Gout

Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.

November 28th 2022

Atlantic Health System Tests Novel CAR-T Cell Therapy for Lupus in First US Patient

Allopurinol exposures of 100 mg or more than 100 mg were associated with lower odds of first-ever ACS with some differences between sexes, a new study reports.

Related Content

February 19th 2024

Antiplatelet Therapy With Aspirin: What Dose in Primary and Secondary Prevention?

In the open-label, phase 1 study, participants' own T cells will be extracted and engineered to target and eliminate autoreactive B cells and to potentially reset the immune system.

June 15th 2012

New-Onset Inflammatory Rheumatic Diseases May be Triggered by SARS-CoV-2 Infection or COVID-19 Vaccines, According to Recent Data

Use of aspirin in primary prevention of cardiovascular disease must be based on individual risk-benefit analysis and is not appropriate for patients at low risk.

August 25th 2023

The New Oral Anticoagulants: Benefits, Risks, Patient Selection

Findings from a recent study show a broad spectrum of possible clinical manifestations of IRD following SARS-CoV-2 infection or COVID-19 vaccination.

May 22nd 2012

First Opioid Rx Leads to Long-term Use in 1 of 5 with Rheumatic or Musculoskeletal Disorders

The European Society of Cardiology just weighed in on the 3 new alternatives to warfarin for oral anticoagulation. The response is tempered enthusiasm.

May 17th 2023

Allopurinol May Help Prevent First ACS Event in Patients with Gout

Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.

November 28th 2022